Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Lower SHBG levels may increase the risk of PCOS.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.